KATERINA CERMAKOVA to Humans
This is a "connection" page, showing publications KATERINA CERMAKOVA has written about Humans.
Connection Strength
0.114
-
Pharmacologic Blockade of a Pioneer Transcription Factor. Cancer Res. 2024 Dec 16; 84(24):4124-4125.
Score: 0.024
-
Reactivation of the G1 enhancer landscape underlies core circuitry addiction to SWI/SNF. Nucleic Acids Res. 2024 Jan 11; 52(1):4-21.
Score: 0.023
-
A ubiquitous disordered protein interaction module orchestrates transcription elongation. Science. 2021 Nov 26; 374(6571):1113-1121.
Score: 0.020
-
Next-Generation Drugs and Probes for Chromatin Biology: From Targeted Protein Degradation to Phase Separation. Molecules. 2018 Aug 06; 23(8).
Score: 0.016
-
Lessons Learned: HIV Points the Way Towards Precision Treatment of Mixed-Lineage Leukemia. Trends Pharmacol Sci. 2016 08; 37(8):660-671.
Score: 0.014
-
?-catenin functions as a molecular adapter for disordered cBAF interactions. Mol Cell. 2025 Aug 21; 85(16):3041-3056.e9.
Score: 0.006
-
SWI/SNF Blockade Disrupts PU.1-Directed Enhancer Programs in Normal Hematopoietic Cells and Acute Myeloid Leukemia. Cancer Res. 2023 04 04; 83(7):983-996.
Score: 0.005
-
Dominant-negative SMARCA4 mutants alter the accessibility landscape of tissue-unrestricted enhancers. Nat Struct Mol Biol. 2018 01; 25(1):61-72.
Score: 0.004
-
Synthesis and antimicrobial evaluation of new 2-substituted 5,7-di-tert-butylbenzoxazoles. Bioorg Med Chem. 2006 Sep 01; 14(17):5850-65.
Score: 0.002